Pharma-Bio Serv Announces Special Dividend

Arizona Tribune - Pharma-Bio Serv Announces Special Dividend

Pharma-Bio Serv Announces Special Dividend

DORADO, PUERTO RICO / ACCESS Newswire / January 29, 2025 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries, today announced that the Board of Directors approved a Special Dividend of $0.075 per share for shareholders. The Special Dividend will be payable on or about March 20, 2025 to shareholders of record at the close of business on February 28, 2025.

Text size:

About Pharma-Bio Serv, Inc.

Pharma-Bio Serv services the Puerto Rico, United States, Europe and Latin America markets. Pharma-Bio Serv's core business is FDA and international agencies regulatory compliance consulting related services. The Company's global team includes leading engineering and life science professionals, quality assurance managers and directors.

Forward-Looking Statements

This news release contains "forward-looking statements" within the meaning of the U.S. federal securities laws, which statements may include information regarding the plans, intentions, expectations, future financial performance, or future operating performance of Pharma-Bio Serv. Forward-looking statements are based on the expectations, estimates, or projections of management as of the date of this news release. Although Pharma-Bio Serv's management believes these expectations, estimates, or projections to be reasonable as of the date of this news release, forward-looking statements are inherently subject to significant business risks, economic uncertainties, competitive uncertainties, and other factors, which could cause its actual results or performance to differ materially from what may be expressed or implied in the forward-looking statements. Important factors that could cause Pharma-Bio Serv's actual results or performance to differ materially from the forward-looking statements include those set forth in the "Risk Factors" section of Pharma-Bio Serv's most recent Annual Report on Form 10-K, and in its other filings with the Securities and Exchange Commission, which filings are available on www.sec.gov. Pharma-Bio Serv disclaims any intention or obligation to update or revise any forward-looking statements to reflect subsequent events and circumstances, except to the extent required by applicable law.

Company Contact:

Pedro J. Lasanta
Chief Financial Officer
787 278 2709

SOURCE: Pharma-Bio Serv, Inc.

View the original press release on ACCESS Newswire

H.Thompson--AT

CMSC	-1.54%	19.5	$
BCC	-2.36%	67.92	$
BCE	-0.75%	21.35	$
RELX	-0.15%	40.04	$
RBGPF	1.12%	76.02	$
NGG	0.41%	83.6	$
CMSD	-2.15%	19.51	$
GSK	0.08%	50.64	$
RIO	-2.03%	83.28	$
RYCEF	-3.64%	17.31	$
JRI	-1.3%	11.56	$
BTI	-0.02%	61.04	$
VOD	-0.97%	15.49	$
AZN	-0.6%	184.38	$
BP	1.22%	45.82	$

Arizona Tribune - Pharma-Bio Serv Announces Special Dividend

Pharma-Bio Serv Announces Special Dividend

Featured

General Hospital actor Randall England dies at 75

Bunnie XO artwork taken down from Jelly Roll’s Nashville bar

London museum removes Russell Brand hair exhibit after rape conviction

Kylie Jenner employee describes closet ordeal and pepper-spray incident